Skip to main content
. 2022 Apr 26;10(5):998. doi: 10.3390/biomedicines10050998

Table 1.

Demographic data in TN patients and controls.

Variables TN Controls p-Value
Patients, n 16 16
Age (years), median (IQR) 66 (55–69) 67 (52–72) 1.00
Sex (female/male), n (%) 7/9 (44/56%) 6/10 (38/63%) 0.72
BMI, median (IQR) 28 (24–31) 28 (24–31) 0.93
Tobacco use, n (%) 4 (25%) 8 (50%) 0.14
Hypertension, n (%) 8 (50%) 9 (56%) 0.72
Cardiovascular morbidity, n (%) 2 (13%) 5 (31%) 0.22
Ischemic heart disease, n (%) 1 (6%) 3 (19%)
Stroke, n (%) 1 (6%) 1 (6%)
Peripheral, n (%) 0 (0%) 1 (6%)
Diabetes mellitus, n (%) 0 (0%) 3 (19%) 0.07
Pain other than TN, n (%) 4 (25%) 5 (31%) 0.69
Fibromyalgia, n (%) 1 (6%) 0 (0%)
Osteoarthtritis, n (%) 2 (13%) 2 (13%)
Lower back pain, n (%) 1 (6%) 2 (13%)
Rheumatoid arthritis, n (%) 1 (6%) 1 (6%)
ASA grade 0.83
1, n (%) 2 (13%) 2 (13%)
2, n (%) 13 (81%) 12 (75%)
3, n (%) 1 (6%) 2 (13%)

Lumbar CSF—in TN patients and controls.